PERMETHRIN CREAM 5%

Manufacturer
Central Texas Community Health Centers | Travis County Healthcare District
Effective date
2018-04-26
Label type
HUMAN PRESCRIPTION DRUG LABEL
Version
4
Source
full-release
Hydrated at
2026-05-31 20:25:40

Label at a glance#

ProductPermethrin
Active ingredientPERMETHRIN
Label structure12 sections

Indications and uses

Permethrin cream is indicated for the treatment of infestation with Sarcoptes scabiei (scabies).

Dosage and administration

Adults and children: Thoroughly massage permethrin cream into the skin from the head to the soles of the feet. Scabies rarely infests the scalp of adults, although the hairline, neck, temple, and forehead may be infested in infants and geriatric patients. Usually 30 grams is sufficient for an average adult. The cream should be removed by washing (shower or bath) after 8 to 14 hours. Infants should be treated on th...

Label contents#

Full prescribing information#

SPL UNCLASSIFIED SECTION


Rx Only

DESCRIPTION

DESCRIPTION SECTION

Permethrin Cream 5% is a topical scabicidal agent for the treatment of infestation with Sarcoptes scabiei (scabies). It is available in a white to off-white, vanishing cream base.

Permethrin cream is for topical use only.

Structural Formula:

fc7b7123-figure-01fc7b7123-figure-01

Chemical Name: The permethrin used is an approximate 1:3 mixture of the cis and trans isomers of the pyrethroid 3-(2,2-dichloroethenyl)- 2,2-dimethylcyclopropanecarboxylic acid, (3-phenoxyphenyl) methyl ester. Permethrin has a molecular formula of C21H20Cl2O3 and a molecular weight of 391.29. It is a yellow to light orange-brown, low melting solid or viscous liquid.

Each gram contains permethrin 50 mg (5%) and the inactive ingredients butylated hydroxytoluene, carbomer 934P, coconut oil, glycerin, glyceryl stearate, isopropyl myristate, lanolin alcohols, light mineral oil, polyoxyethylene cetyl ethers, purified water, and sodium hydroxide. Formaldehyde 1 mg (0.1%) is added as a preservative.

CLINICAL PHARMACOLOGY

CLINICAL PHARMACOLOGY SECTION

Permethrin, a pyrethroid, is active against a broad range of pests including lice, ticks, fleas, mites, and other arthropods. It acts on the nerve cell membrane to disrupt the sodium channel current by which the polarization of the membrane is regulated. Delayed repolarization and paralysis of the pests are the consequences of this disturbance.

Permethrin is rapidly metabolized by ester hydrolysis to inactive metabolites which are excreted primarily in the urine. Although the amount of permethrin absorbed after a single application of the 5% cream has not been determined precisely, data from studies with 14C-labeled permethrin and absorption studies of the cream applied to patients with moderate to severe scabies indicate it is 2% or less of the amount applied.

INDICATIONS AND USAGE

INDICATIONS & USAGE SECTION

Permethrin cream is indicated for the treatment of infestation with Sarcoptes scabiei (scabies).

CONTRAINDICATIONS

CONTRAINDICATIONS SECTION

Permethrin cream is contraindicated in patients with known hypersensitivity to any of its components, to any synthetic pyrethroid or pyrethrin.

WARNINGS

WARNINGS SECTION

If hypersensitivity to permethrin cream occurs, discontinue use.

PRECAUTIONS

PRECAUTIONS SECTION

General

GENERAL PRECAUTIONS SECTION

Scabies infestation is often accompanied by pruritis, edema and erythema. Treatment with permethrin cream may temporarily exacerbate these conditions.

Information for Patients

SPL UNCLASSIFIED SECTION

Patients with scabies should be advised that itching, mild burning and/or stinging may occur after application of permethrin cream. In clinical trials, approximately 75% of patients treated with permethrin cream who continued to manifest pruritis at 2 weeks had cessation by 4 weeks. If irritation persists, they should consult their physician. Permethrin cream may be very mildly irritating to the eyes. Patients should be advised to avoid contact with eyes during application and to flush with water immediately if permethrin cream gets in the eyes.

Carcinogenesis, Mutagenesis, Impairment of Fertility

SPL UNCLASSIFIED SECTION

Six carcinogenicity bioassays were evaluated with permethrin, three each in rats and mice. No tumorigenicity was seen in the rat studies. However, species-specific increases in pulmonary adenomas, a common benign tumor of mice of high spontaneous background incidence, were seen in the three mouse studies. In one of these studies there was an increased incidence of pulmonary alveolar-cell carcinomas and benign liver adenomas only in female mice when permethrin was given in their food at a concentration of 5000 ppm. Mutagenicity assays, which give useful correlative data for interpreting results from carcinogenicity bioassays in rodents, were negative. Permethrin showed no evidence of mutagenic potential in a battery of in vitro and in vivo genetic toxicity studies.

Permethrin did not have any adverse effect on reproductive function at a dose of 180 mg/kg/day orally in a three-generation rat study.

Pregnancy

SPL UNCLASSIFIED SECTION

Teratogenic Effects

SPL UNCLASSIFIED SECTION

Pregnancy Category B: Reproduction studies have been performed in mice, rats, and rabbits (200 to 400 mg/kg/day orally) and have revealed no evidence of impaired fertility or harm to the fetus due to permethrin. There are, however, no adequate and well-controlled studies in pregnant women. Because animal reproduction studies are not always predictive of human response, this drug should be used during pregnancy only if clearly needed.

Nursing Mothers

SPL UNCLASSIFIED SECTION

It is not known whether this drug is excreted in human milk. Because many drugs are excreted in human milk and because of the evidence for tumorigenic potential of permethrin in animal studies, consideration should be given to discontinuing nursing temporarily or withholding the drug while the mother is nursing.

Pediatric Use

SPL UNCLASSIFIED SECTION

Permethrin cream is safe and effective in pediatric patients two months of age and older. Safety and effectiveness in pediatric patients less than two months of age have not been established.

Geriatric Use

SPL UNCLASSIFIED SECTION

Clinical studies of permethrin cream did not identify sufficient numbers of subjects aged 65 and over to allow a definitive statement regarding whether elderly subjects respond differently from younger subjects. Other reported clinical experience has not identified differences in responses between the elderly and younger patients. This drug is known to be substantially excreted by the kidney. However, since topical permethrin is metabolized in the liver and excreted in the urine as inactive metabolites, there does not appear to be an increased risk of toxic reactions in patients with impaired renal function when used as labeled.

ADVERSE REACTIONS

ADVERSE REACTIONS SECTION

In clinical trials, generally mild and transient burning and stinging followed application with permethrin cream in 10% of patients and was associated with the severity of infestation. Pruritis was reported in 7% of patients at various times post-application. Erythema, numbness, tingling, and rash were reported in 1 to 2% or less of patients (see PRECAUTIONS: General).

OVERDOSAGE

OVERDOSAGE SECTION

No instance of accidental ingestion of permethrin cream has been reported. If ingested, gastric lavage and general supportive measures should be employed.

DOSAGE AND ADMINISTRATION

DOSAGE & ADMINISTRATION SECTION

Adults and children: Thoroughly massage permethrin cream into the skin from the head to the soles of the feet. Scabies rarely infests the scalp of adults, although the hairline, neck, temple, and forehead may be infested in infants and geriatric patients. Usually 30 grams is sufficient for an average adult. The cream should be removed by washing (shower or bath) after 8 to 14 hours. Infants should be treated on the scalp, temple and forehead. ONE APPLICATION IS GENERALLY CURATIVE.

Patients may experience persistent pruritus after treatment. This is rarely a sign of treatment failure and is not an indication for retreatment. Demonstrable living mites after 14 days indicate that retreatment is necessary.

HOW SUPPLIED

HOW SUPPLIED SECTION

Product: 76413-159

NDC: 76413-159-60 60 g in a TUBE

PERMETHRIN CREAM

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Label Image
Label Image

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYSPL version
106387permethrin 5 % Topical CreamPSN4
106387permethrin 50 MG/ML Topical CreamSCD4
106387permethrin 5 % Topical CreamSY4

DailyMed Pharmacologic Classes#

Class, Version, Type table
ClassVersionTypeEffective
PERMETHRIN Pharmacologic Class Indexing2Indexing - Pharmacologic Class20180813

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
f33e3e13-1328-47a9-3012-134a14fcb6a1Product name220190703

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
76413-159-602020-01-31C16284748780-19d75b9cf-ce69-f424-e053-dadaa90a57cePERMETHRIN CREAM 5%

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
76413-159-60Permethrin60 g in 1 TUBECREAM604

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
76413-159PERMETHRIN CREAM [CENTRAL TEXAS COMMUNITY HEALTH CENTERS]4Legacy NDC, 1 package rows20180427_d34031b1-0c4e-48e4-8d5c-9c63933c8147.zip

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
0472-0242-60GM - Gram0472-0242031c473a-d21e-4f1e-ac7d-db1813b5d31c12013-02-13

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 14 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
76413-15976413-159-60
0472-0242

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 14 matching rows.

Source Document#

Source XML · Source PDF

Orange Book application contexts#

All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.

Orange Book application contexts page 1 of 1 · 1 matching rows.

Source provenance: Browse the complete Orange Book source catalog · source snapshot 43.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
A074806-001PERMETHRINPERMETHRIN5%CREAM / TOPICAL1998-01-23

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 43 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-09-14 22:38:342026-08A074806-001PERMETHRIN5%CREAM / TOPICAL1998-01-2384e616aacf4f…
2026-08-18 06:07:402026-07A074806-001PERMETHRIN5%CREAM / TOPICALAB1998-01-23caaa826d4ba7…
2026-02-19 14:30 UTC2026-02A074806-001PERMETHRIN5%CREAM / TOPICALAB1998-01-23011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A074806-001PERMETHRIN5%CREAM / TOPICALAB1998-01-2331067a03dcf5…
2025-08-23 18:47 UTC2025-08A074806-001PERMETHRIN5%CREAM / TOPICALAB1998-01-236a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A074806-001PERMETHRIN5%CREAM / TOPICALAB1998-01-23fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A074806-001PERMETHRIN5%CREAM / TOPICALAB1998-01-23b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A074806-001PERMETHRIN5%CREAM / TOPICALAB1998-01-2303ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A074806-001PERMETHRIN5%CREAM / TOPICALAB1998-01-232680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A074806-001PERMETHRIN5%CREAM / TOPICALAB1998-01-235bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A074806-001PERMETHRIN5%CREAM / TOPICALAB1998-01-23d8e5a09893c0…
2024-10-29 15:01 UTC2024-10A074806-001PERMETHRIN5%CREAM / TOPICALAB1998-01-23d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A074806-001PERMETHRIN5%CREAM / TOPICALAB1998-01-2379d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07A074806-001PERMETHRIN5%CREAM / TOPICALAB1998-01-23301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06A074806-001PERMETHRIN5%CREAM / TOPICALAB1998-01-231e350fbaab3a…
2024-05-31 18:47 UTC2024-05A074806-001PERMETHRIN5%CREAM / TOPICALAB1998-01-238072bd15b7f6…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06A074806-001PERMETHRIN5%CREAM / TOPICALAB1998-01-235c6f7cd8ea54…
2022-04-08 23:34 UTC2022-04A074806-001PERMETHRIN5%CREAM / TOPICALAB1998-01-235d02ea3f76ae…
2022-04-04 05:41 UTC2022-04A074806-001PERMETHRIN5%CREAM / TOPICALAB1998-01-234b0b4de00fa7…
2019-12-13 00:20 UTC2019-12A074806-001PERMETHRIN5%CREAM / TOPICALAB1998-01-2374a2ff9319b5…
2022-03-09 01:35 UTC2022-03A074806-001PERMETHRIN5%CREAM / TOPICALAB1998-01-23bb7c543d1eb4…
2021-12-28 21:50 UTC2021-12A074806-001PERMETHRIN5%CREAM / TOPICALAB1998-01-23782e0a99824c…
2021-05-05 16:15 UTC · 3 captures of this ZIP2021-05A074806-001PERMETHRIN5%CREAM / TOPICALAB1998-01-2387673890dc5c…
2021-03-12 10:30 UTC2021-03A074806-001PERMETHRIN5%CREAM / TOPICALAB1998-01-235aa47cf7b7d7…
2020-12-22 03:56 UTC2020-12A074806-001PERMETHRIN5%CREAM / TOPICALAB1998-01-238869cabd3fbd…
2020-11-12 02:37 UTC2020-11A074806-001PERMETHRIN5%CREAM / TOPICALAB1998-01-23c0c555d07b60…
2019-12-14 00:12 UTC2019-12A074806-001PERMETHRIN5%CREAM / TOPICALAB1998-01-233f01610625f2…
2019-09-15 20:21 UTC2019-09A074806-001PERMETHRIN5%CREAM / TOPICALAB1998-01-23b00525d2431f…
2019-07-19 19:46 UTC2019-07A074806-001PERMETHRIN5%CREAM / TOPICALAB1998-01-23ea99ee380514…
2024-03-16 18:09 UTC · 4 captures of this ZIP2024-03A074806-001PERMETHRIN5%CREAM / TOPICALAB1998-01-236a51e52b5d6a…
2024-02-18 07:12 UTC2024-02A074806-001PERMETHRIN5%CREAM / TOPICALAB1998-01-231c564ffb4f44…
2023-12-20 04:57 UTC2023-12A074806-001PERMETHRIN5%CREAM / TOPICALAB1998-01-23ea1830bbd6c7…
2023-11-28 05:40 UTC · 2 captures of this ZIP2023-11A074806-001PERMETHRIN5%CREAM / TOPICALAB1998-01-23a72a2bbeb626…
2023-10-25 00:34 UTC · 2 captures of this ZIP2023-10A074806-001PERMETHRIN5%CREAM / TOPICALAB1998-01-239b2671bbb829…
2023-07-15 15:27 UTC · 2 captures of this ZIP2023-07A074806-001PERMETHRIN5%CREAM / TOPICALAB1998-01-23a67488948f0b…
2023-06-13 01:57 UTC · 3 captures of this ZIP2023-06A074806-001PERMETHRIN5%CREAM / TOPICALAB1998-01-233f0d92c62455…
2023-05-13 08:27 UTC2023-05A074806-001PERMETHRIN5%CREAM / TOPICALAB1998-01-23053a50430f4f…
2023-01-26 05:58 UTC2023-01A074806-001PERMETHRIN5%CREAM / TOPICALAB1998-01-233bdfa0b2c4d7…
2022-11-12 20:34 UTC · 5 captures of this ZIP2022-11A074806-001PERMETHRIN5%CREAM / TOPICALAB1998-01-233a93d1ddd44b…
2022-10-28 04:53 UTC2022-10A074806-001PERMETHRIN5%CREAM / TOPICALAB1998-01-23f41ea6bd6efb…

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 2 · 42 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTE codeOrderSource SHA-256
2026-08-18 06:07:402026-07A074806-001AB1caaa826d4ba7…
2026-02-19 14:30 UTC2026-02A074806-001AB1011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A074806-001AB131067a03dcf5…
2025-08-23 18:47 UTC2025-08A074806-001AB16a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A074806-001AB1fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A074806-001AB1b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A074806-001AB103ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A074806-001AB12680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A074806-001AB15bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A074806-001AB1d8e5a09893c0…
2024-10-29 15:01 UTC2024-10A074806-001AB1d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A074806-001AB179d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07A074806-001AB1301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06A074806-001AB11e350fbaab3a…
2024-05-31 18:47 UTC2024-05A074806-001AB18072bd15b7f6…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06A074806-001AB15c6f7cd8ea54…
2022-04-08 23:34 UTC2022-04A074806-001AB15d02ea3f76ae…
2022-04-04 05:41 UTC2022-04A074806-001AB14b0b4de00fa7…
2019-12-13 00:20 UTC2019-12A074806-001AB174a2ff9319b5…
2022-03-09 01:35 UTC2022-03A074806-001AB1bb7c543d1eb4…
2021-12-28 21:50 UTC2021-12A074806-001AB1782e0a99824c…
2021-05-05 16:15 UTC · 3 captures of this ZIP2021-05A074806-001AB187673890dc5c…
2021-03-12 10:30 UTC2021-03A074806-001AB15aa47cf7b7d7…
2020-12-22 03:56 UTC2020-12A074806-001AB18869cabd3fbd…
2020-11-12 02:37 UTC2020-11A074806-001AB1c0c555d07b60…
2019-12-14 00:12 UTC2019-12A074806-001AB13f01610625f2…
2019-09-15 20:21 UTC2019-09A074806-001AB1b00525d2431f…
2019-07-19 19:46 UTC2019-07A074806-001AB1ea99ee380514…
2024-03-16 18:09 UTC · 4 captures of this ZIP2024-03A074806-001AB16a51e52b5d6a…
2024-02-18 07:12 UTC2024-02A074806-001AB11c564ffb4f44…
2023-12-20 04:57 UTC2023-12A074806-001AB1ea1830bbd6c7…
2023-11-28 05:40 UTC · 2 captures of this ZIP2023-11A074806-001AB1a72a2bbeb626…
2023-10-25 00:34 UTC · 2 captures of this ZIP2023-10A074806-001AB19b2671bbb829…
2023-07-15 15:27 UTC · 2 captures of this ZIP2023-07A074806-001AB1a67488948f0b…
2023-06-13 01:57 UTC · 3 captures of this ZIP2023-06A074806-001AB13f0d92c62455…
2023-05-13 08:27 UTC2023-05A074806-001AB1053a50430f4f…
2023-01-26 05:58 UTC2023-01A074806-001AB13bdfa0b2c4d7…
2022-11-12 20:34 UTC · 5 captures of this ZIP2022-11A074806-001AB13a93d1ddd44b…
2022-10-28 04:53 UTC2022-10A074806-001AB1f41ea6bd6efb…
2022-09-29 23:25 UTC2022-09A074806-001AB1e64feba35796…

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
8ade776f-4218-4c21-8652-efa928ac8c30d34031b1-0c4e-48e4-8d5c-9c63933c81472018-04-26Warnings, Adverse reactionsExact identifier
spl id: 8ade776f-4218-4c21-8652-efa928ac8c30
spl set id: d34031b1-0c4e-48e4-8d5c-9c63933c8147

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.